Literature DB >> 34424812

Up-regulation of miR-663a inhibits the cancer stem cell-like properties of glioma via repressing the KDM2A-mediated TGF-β/SMAD signaling pathway.

Lei Wang1,2, Bojuan Lang1,3, Youdong Zhou1,2, Jinyang Ma1,2, Keqi Hu4.   

Abstract

Emerging reports have shown that microRNAs (miRNAs) function as vital regulators in tumor development via modulating gene expression at the posttranscriptional level. Here, we explored the role and underlying mechanism of miR-663a in the proliferation, migration, invasion, and cancer stem cell-like (CSC) properties of glioma cells. Quantitative reverse transcription PCR (qRT-PCR) was implemented to detect miR-663a expression in glioblastoma tissues and the adjacent normal tissues. Additionally, gain- and loss-of-function assays of miR-633a were performed on U-251 MG cells or human primary glioblastoma cancer cells (pGBMC1). Cell proliferation, migration, invasion, CSC properties, and profiles of stem cell markers (including CD133, CD44) were examined by the MTT assay, Transwell assay, tumorsphere experiment, and Western blotting, respectively. The dual-luciferase reporter gene assay was performed to testify the targeted relationship between miR-663a and lysine demethylase 2A (KDM2A). The results showed that miR-663a was down-regulated in glioblastoma tissues and cells. Overexpressing miR-663a repressed the proliferation, migration, invasion, CSC properties of U-251 MG cells and pGBMC1, while miR-663a knockdown had the opposite effects. The in-vivo experiment confirmed that miR-663a repressed the growth of U-251 MG cells in nude mice. When cocultured with THP1 cells, U-251 MG cells gained enhanced proliferation, migration, invasion, and CSC properties. MiR-633a overexpression reversed THP1-mediated effects on U-251 MG cells, and reduced the "M2" polarization of THP1 cells. What's more, Mechanistically, KDM2A was targeted by miR-663a. KDM2A knockdown suppressed the progression and CSC properties of U-251 MG cells in vitro, and dampened TGF-β. Overall, those data revealed that up-regulating miR-663a reduced glioma progression by inhibiting the KDM2A-mediated TGF-β/Smad pathway.

Entities:  

Keywords:  Glioma; KDM2A; TGF-β; macrophages; miR-663a; stemness

Mesh:

Substances:

Year:  2021        PMID: 34424812      PMCID: PMC8565824          DOI: 10.1080/15384101.2021.1966962

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  46 in total

1.  KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling.

Authors:  Klaus W Wagner; Hunain Alam; Shilpa S Dhar; Uma Giri; Na Li; Yongkun Wei; Dipak Giri; Tina Cascone; Jae-Hwan Kim; Yuanqing Ye; Asha S Multani; Chia-Hsin Chan; Baruch Erez; Babita Saigal; Jimyung Chung; Hui-Kuan Lin; Xifeng Wu; Mien-Chie Hung; John V Heymach; Min Gyu Lee
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

Review 2.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

Review 3.  CNS macrophages and peripheral myeloid cells in brain tumours.

Authors:  Rainer Glass; Michael Synowitz
Journal:  Acta Neuropathol       Date:  2014-04-11       Impact factor: 17.088

4.  miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.

Authors:  Weizhen Huang; Jun Li; Xiaohong Guo; Yingchu Zhao; Xia Yuan
Journal:  Biomed Pharmacother       Date:  2016-04-28       Impact factor: 6.529

5.  Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.

Authors:  Yufeng Huang; Yiqian Liu; Lijiang Yu; Jing Chen; Juan Hou; Lihua Cui; De Ma; Wangkun Lu
Journal:  Tumour Biol       Date:  2014-09-23

6.  Underlying mechanism of the photodynamic activity of hematoporphyrin‑induced apoptosis in U87 glioma cells.

Authors:  Shi-Xiang Yuan; Jun-Liang Li; Xin-Ke Xu; Wei Chen; Cheng Chen; Kun-Qi Kuang; Fang-Yu Wang; Kai Wang; Fang-Cheng Li
Journal:  Int J Mol Med       Date:  2018-01-18       Impact factor: 4.101

7.  Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR.

Authors:  Xiaofan Guo; Hao Xue; Qianqian Shao; Jian Wang; Xing Guo; Xi Chen; Jinsen Zhang; Shugang Xu; Tong Li; Ping Zhang; Xiao Gao; Wei Qiu; Qinglin Liu; Gang Li
Journal:  Oncotarget       Date:  2016-12-06

Review 8.  MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.

Authors:  Qian Zhou; Jing Liu; Jing Quan; Wenlan Liu; Hui Tan; Weiping Li
Journal:  Cancer Sci       Date:  2018-08-03       Impact factor: 6.716

9.  EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway.

Authors:  Qiang Ma; Yijian Zhang; Haibin Liang; Fei Zhang; Fatao Liu; Shili Chen; Yunping Hu; Lin Jiang; Yajuan Hao; Maolan Li; Yingbin Liu
Journal:  Cancer Lett       Date:  2018-05-17       Impact factor: 9.756

Review 10.  When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.

Authors:  Saskia Roesch; Carmen Rapp; Steffen Dettling; Christel Herold-Mende
Journal:  Int J Mol Sci       Date:  2018-02-01       Impact factor: 5.923

View more
  1 in total

Review 1.  Cancer Stem Cells and Their Vesicles, Together with Other Stem and Non-Stem Cells, Govern Critical Cancer Processes: Perspectives for Medical Development.

Authors:  Jacopo Meldolesi
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.